Anika Therapeutics (ANIK) Names CFO

January 22, 2013 8:34 AM EST Send to a Friend
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced the appointment of Sylvia Cheung as the company’s Chief Financial Officer, effective April 1, 2013. Cheung, who has served as Anika’s Vice President for Strategic Processes since February 2012, will succeed Kevin W. Quinlan, who is leaving Anika effective March 31, 2013 to pursue other professional opportunities. The company also today provided its preliminary unaudited revenue results for the fourth quarter and full year ended December 31, 2012.

Cheung, 38, brings to Anika more than 16 years of financial and general management experience. Prior to her current position as Vice President of Strategic Processes, Cheung served as General Manager for the company’s Italy-based subsidiary, Anika Srl. She joined Anika as Controller in 2005. In addition to fulfilling wide-ranging financial responsibilities as Controller, Cheung led the company’s integration of Anika Srl subsequent to its acquisition in 2009. Prior to Anika, she held a series of progressively responsible financial management positions at Transkaryotic Therapies, Inc. Cheung holds a bachelor of business administration degree in accounting from the University of Massachusetts in Amherst, a master’s degree in business administration from Boston University, and is a Certified Public Accountant (inactive).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Management Changes

Add Your Comment